Explore
Validate
Learn
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA008275 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA008275, RRID:AB_1849497
- Product name
- Anti-GAS6
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human GAS6, Gene description: growth arrest-specific 6, Alternative Gene Names: AXLLG, AXSF, DKFZp666G247, FLJ34709, Validated applications: IHC, Uniprot ID: Q14393, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.4 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references AXL Inhibition in Macrophages Stimulates Host-versus-Leukemia Immunity and Eradicates Naïve and Treatment-Resistant Leukemia
Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma
The expression of Axl receptor tyrosine kinase influences the tumour phenotype and clinical outcome of patients with malignant pleural mesothelioma
Tirado-Gonzalez I, Descot A, Soetopo D, Nevmerzhitskaya A, Schäffer A, Kur I, Czlonka E, Wachtel C, Tsoukala I, Müller L, Schäfer A, Weitmann M, Dinse P, Alberto E, Buck M, Landry J, Baying B, Slotta-Huspenina J, Roesler J, Harter P, Kubasch A, Meinel J, Elwakeel E, Strack E, Quang C, Abdel-Wahab O, Schmitz M, Weigert A, Schmid T, Platzbecker U, Benes V, Ghysdael J, Bonig H, Götze K, Rothlin C, Ghosh S, Medyouf H
Cancer Discovery 2021;11(11):2924-2943
Cancer Discovery 2021;11(11):2924-2943
Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma
Pinato D, Brown M, Trousil S, Aboagye E, Beaumont J, Zhang H, Coley H, Mauri F, Sharma R
British Journal of Cancer 2019;120(5):512-521
British Journal of Cancer 2019;120(5):512-521
The expression of Axl receptor tyrosine kinase influences the tumour phenotype and clinical outcome of patients with malignant pleural mesothelioma
Pinato D, Mauri F, Lloyd T, Vaira V, Casadio C, Boldorini R, Sharma R
British Journal of Cancer 2013;108(3):621-628
British Journal of Cancer 2013;108(3):621-628
No comments: Submit comment
No validations: Submit validation data